Back
BioCryst Pharmaceuticals, Inc. Stock Price Chart
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.
Sell
31
BCRX
BioCryst Pharmaceuticals, Inc.
Last Price:
$6.80
Seasonality Move:
-4.33%
7 Day Trial
ALL ACCESS PASS
$
7
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCRX is experiencing slight buying pressure.
BioCryst Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.82 | Sell |
| 20-day SMA: | 7.3 | Sell |
| 50-day SMA: | 7.3 | Sell |
| 200-day SMA: | 8.22 | Sell |
| 8-day EMA: | 6.89 | Sell |
| 20-day EMA: | 7.14 | Sell |
| 50-day EMA: | 7.29 | Sell |
| 200-day EMA: | 7.76 | Sell |
BioCryst Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 40.24 | Sell |
| Chaikin Money Flow: | 130816 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.93 - 7.71) | Sell |
| Bollinger Bands (100): | (6.94 - 7.8) | Sell |
BioCryst Pharmaceuticals, Inc. Technical Analysis
| Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioCryst Pharmaceuticals, Inc. Stock
Is BioCryst Pharmaceuticals, Inc. Stock a Buy?
-
BioCryst Pharmaceuticals, Inc. share price is 6.75 while BCRX 8-day simple moving average is 6.82, which is a Sell signal.
-
The stock price of BCRX is 6.75 while BioCryst Pharmaceuticals, Inc. 20-day SMA is 7.30, which makes it a Sell.
-
BioCryst Pharmaceuticals, Inc. 50-day simple moving average is 7.30 while BCRX share price is 6.75, making it a Sell technically.
-
BCRX stock price is 6.75 and BioCryst Pharmaceuticals, Inc. 200-day simple moving average is 8.22, creating a Sell signal.
BCRX Technical Analysis vs Fundamental Analysis
Sell
31
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Sell
Is BioCryst Pharmaceuticals, Inc. a Buy or a Sell?
-
BioCryst Pharmaceuticals, Inc. stock is rated a SellThe current BioCryst Pharmaceuticals, Inc. [BCRX] share price is $6.75. The Score for BCRX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
BioCryst Pharmaceuticals, Inc. Stock Info
Market Cap:
1.4B
Price in USD:
6.75
Share Volume:
6.7M
BioCryst Pharmaceuticals, Inc. 52-Week Range
52-Week High:
11.31
52-Week Low:
6.00
Sell
31
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Sell
BioCryst Pharmaceuticals, Inc. Share Price Forecast
-
What is the BioCryst Pharmaceuticals, Inc. stock price today?The BioCryst Pharmaceuticals, Inc. stock price is 6.75 USD today.
-
Will BCRX stock go up or go down?BioCryst Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is BioCryst Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioCryst Pharmaceuticals, Inc. is overvalued.
Is BioCryst Pharmaceuticals, Inc. Stock a Buy?
-
BioCryst Pharmaceuticals, Inc. share price is 6.75 while BCRX 8-day exponential moving average is 6.89, which is a Sell signal.
-
The stock price of BCRX is 6.75 while BioCryst Pharmaceuticals, Inc. 20-day EMA is 7.14, which makes it a Sell.
-
BioCryst Pharmaceuticals, Inc. 50-day exponential moving average is 7.29 while BCRX share price is 6.75, making it a Sell technically.
-
BCRX stock price is 6.75 and BioCryst Pharmaceuticals, Inc. 200-day simple moving average is 7.76, creating a Sell signal.
Fundamental Analysis of BioCryst Pharmaceuticals, Inc.
Is BioCryst Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.23 per share.
Technical Analysis of BioCryst Pharmaceuticals, Inc.
Should I short BioCryst Pharmaceuticals, Inc. stock?
-
BCRX Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting BioCryst Pharmaceuticals, Inc. is a Sell
-
BioCryst Pharmaceuticals, Inc. Relative Strength Index (RSI) is 40.24, which suggest BioCryst Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for BioCryst Pharmaceuticals, Inc. is (6.93 - 7.71), which suggest BioCryst Pharmaceuticals, Inc. is a Sell
-
The Bollinger Bands (100) for BioCryst Pharmaceuticals, Inc. is (6.94 - 7.8), which suggest BioCryst Pharmaceuticals, Inc. is a Sell
* BioCryst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.